Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest half life in humans after IV administration.
Constraint: You must select all options from a, b, c, or d without using any other words.
Options:
[a] CC(=O)O[C@H]1C[C@]2(C)CC[C@H]3[C@@H]4C[C@H](N5CC[N+](C)(C)CC5)[C@H](OC(C)=O)[C@@]4(C)CC[C@@H]3[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1.[Br-].[Br-]
[b] CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl
[c] CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(O)nn3C)CS[C@H]12)c1csc(N)n1
[d] CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
Answer: a
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
[(2S,3S,5S,8R,9S,10R,13S,14S,16S,17R)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-5,10,13-trimethyl-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate;dibromide